Guggenheim Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Sell |
|
|||||
|
2025
Q1 | $1.94M | Buy |
|
|||||
|
2024
Q4 | $1.9M | Sell |
|
|||||
|
2024
Q3 | $3.4M | Sell |
|
|||||
|
2024
Q2 | $5.05M | Buy |
|
|||||
|
2024
Q1 | $4.22M | Sell |
|
|||||
|
2023
Q4 | $3.45M | Sell |
|
|||||
|
2023
Q3 | $3.91M | Sell |
|
|||||
|
2023
Q2 | $3.62M | Sell |
|
|||||
|
2023
Q1 | $4.45M | Buy |
|
|||||
|
2022
Q4 | $2.86M | Sell |
|
|||||
|
2022
Q3 | $2.25M | Buy |
|
|||||
|
2022
Q2 | $2.46M | Buy |
|
|||||
|
2022
Q1 | $2.34M | Buy |
|
|||||
|
2021
Q4 | $2.27M | Sell |
|
|||||
|
2021
Q3 | $2.13M | Buy |
|
|||||
|
2021
Q2 | $1.79M | Sell |
|
|||||
|
2021
Q1 | $1.53M | Buy |
|
|||||
|
2020
Q4 | $1.57M | Sell |
|
|||||
|
2020
Q3 | $2.3M | Sell |
|
|||||
|
2020
Q2 | $2.36M | Buy |
|
|||||
|
2020
Q1 | $2.12M | Sell |
|
|||||
|
2019
Q4 | $2.45M | Sell |
|
|||||
|
2019
Q3 | $2.97M | Sell |
|
|||||
|
2019
Q2 | $3.47M | Sell |
|
|||||
|
2019
Q1 | $4.51M | Buy |
|
|||||
|
2018
Q4 | $3.22M | Buy |
|
|||||
|
2018
Q3 | $2.99M | Sell |
|
|||||
|
2018
Q2 | $2.95M | Sell |
|
|||||
|
2018
Q1 | $3.69M | Sell |
|
|||||
|
2017
Q4 | $4.21M | Buy |
|
|||||
|
2017
Q3 | $3.35M | Buy |
|
|||||
|
2017
Q2 | $2.33M | Buy |
|
|||||
|
2017
Q1 | $1.29M | Buy |
|
|||||
|
2016
Q4 | $1.26M | Buy |
|
|||||
|
2016
Q3 | $1.41M | Buy |
|
|||||
|
2016
Q2 | $1.56M | Buy |
|
|||||
|
2016
Q1 | $1.3M | Sell |
|
|||||
|
2015
Q4 | $1.55M | Sell |
|
|||||
|
2015
Q3 | $5.53M | Sell |
|
|||||
|
2015
Q2 | $7.59M | Sell |
|
|||||
|
2015
Q1 | $7.51M | Sell |
|
|||||
|
2014
Q4 | $6.46M | Sell |
|
|||||
|
2014
Q3 | $8.04M | Sell |
|
|||||
|
2014
Q2 | $8.14M | Buy |
|
|||||
|
2014
Q1 | $7.53M | Buy |
|
|||||
|
2013
Q4 | $2.83M | Buy |
|
|||||
|
2013
Q3 | $709K | Buy |
|
|||||
|
2013
Q2 | $315K | Buy |
|